The global market for Swine Inactive Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Swine Inactive Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Swine Inactive Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Swine Inactive Vaccine include Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Shenlian Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Inactive Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Inactive Vaccine.

The Swine Inactive Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Inactive Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Swine Inactive Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Swine Inactive Vaccine Market Report

Report Metric	Details
Report Name	Swine Inactive Vaccine Market
Segment by Type	Mycoplasma Hyopneumoniae Bacterin Vaccine Haemophilus Parasuis Vaccine Porcine Circovirus Type 2 Vaccine Others
Segment by Application	Breeding Farm Veterinary Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Shenlian Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Inactive Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Inactive Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Swine Inactive Vaccine Market report?

Ans: The main players in the Swine Inactive Vaccine Market are Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Shenlian Biomedical

What are the Application segmentation covered in the Swine Inactive Vaccine Market report?

Ans: The Applications covered in the Swine Inactive Vaccine Market report are Breeding Farm, Veterinary Clinic

What are the Type segmentation covered in the Swine Inactive Vaccine Market report?

Ans: The Types covered in the Swine Inactive Vaccine Market report are Mycoplasma Hyopneumoniae Bacterin Vaccine, Haemophilus Parasuis Vaccine, Porcine Circovirus Type 2 Vaccine, Others

1 Swine Inactive Vaccine Market Overview

1.1 Product Definition

1.2 Swine Inactive Vaccine by Type

1.2.1 Global Swine Inactive Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Mycoplasma Hyopneumoniae Bacterin Vaccine

1.2.3 Haemophilus Parasuis Vaccine

1.2.4 Porcine Circovirus Type 2 Vaccine

1.2.5 Others

1.3 Swine Inactive Vaccine by Application

1.3.1 Global Swine Inactive Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Breeding Farm

1.3.3 Veterinary Clinic

1.4 Global Swine Inactive Vaccine Market Size Estimates and Forecasts

1.4.1 Global Swine Inactive Vaccine Revenue 2020-2031

1.4.2 Global Swine Inactive Vaccine Sales 2020-2031

1.4.3 Global Swine Inactive Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Swine Inactive Vaccine Market Competition by Manufacturers

2.1 Global Swine Inactive Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Swine Inactive Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Swine Inactive Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Swine Inactive Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Swine Inactive Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Swine Inactive Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Swine Inactive Vaccine, Date of Enter into This Industry

2.8 Global Swine Inactive Vaccine Market Competitive Situation and Trends

2.8.1 Global Swine Inactive Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Swine Inactive Vaccine Players Market Share by Revenue

2.8.3 Global Swine Inactive Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Swine Inactive Vaccine Market Scenario by Region

3.1 Global Swine Inactive Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Swine Inactive Vaccine Sales by Region: 2020-2031

3.2.1 Global Swine Inactive Vaccine Sales by Region: 2020-2025

3.2.2 Global Swine Inactive Vaccine Sales by Region: 2026-2031

3.3 Global Swine Inactive Vaccine Revenue by Region: 2020-2031

3.3.1 Global Swine Inactive Vaccine Revenue by Region: 2020-2025

3.3.2 Global Swine Inactive Vaccine Revenue by Region: 2026-2031

3.4 North America Swine Inactive Vaccine Market Facts & Figures by Country

3.4.1 North America Swine Inactive Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Swine Inactive Vaccine Sales by Country (2020-2031)

3.4.3 North America Swine Inactive Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Swine Inactive Vaccine Market Facts & Figures by Country

3.5.1 Europe Swine Inactive Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Swine Inactive Vaccine Sales by Country (2020-2031)

3.5.3 Europe Swine Inactive Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Swine Inactive Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Swine Inactive Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Swine Inactive Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Swine Inactive Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Swine Inactive Vaccine Market Facts & Figures by Country

3.7.1 Latin America Swine Inactive Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Swine Inactive Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Swine Inactive Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Swine Inactive Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Swine Inactive Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Swine Inactive Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Swine Inactive Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Swine Inactive Vaccine Sales by Type (2020-2031)

4.1.1 Global Swine Inactive Vaccine Sales by Type (2020-2025)

4.1.2 Global Swine Inactive Vaccine Sales by Type (2026-2031)

4.1.3 Global Swine Inactive Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Swine Inactive Vaccine Revenue by Type (2020-2031)

4.2.1 Global Swine Inactive Vaccine Revenue by Type (2020-2025)

4.2.2 Global Swine Inactive Vaccine Revenue by Type (2026-2031)

4.2.3 Global Swine Inactive Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Swine Inactive Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Swine Inactive Vaccine Sales by Application (2020-2031)

5.1.1 Global Swine Inactive Vaccine Sales by Application (2020-2025)

5.1.2 Global Swine Inactive Vaccine Sales by Application (2026-2031)

5.1.3 Global Swine Inactive Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Swine Inactive Vaccine Revenue by Application (2020-2031)

5.2.1 Global Swine Inactive Vaccine Revenue by Application (2020-2025)

5.2.2 Global Swine Inactive Vaccine Revenue by Application (2026-2031)

5.2.3 Global Swine Inactive Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Swine Inactive Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Company Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Harbin Pharmaceutical Group Bio-vaccine

6.2.1 Harbin Pharmaceutical Group Bio-vaccine Company Information

6.2.2 Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview

6.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio

6.2.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates

6.3 DHN

6.3.1 DHN Company Information

6.3.2 DHN Description and Business Overview

6.3.3 DHN Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 DHN Swine Inactive Vaccine Product Portfolio

6.3.5 DHN Recent Developments/Updates

6.4 Shenzhen BIOCBD Biotechnology

6.4.1 Shenzhen BIOCBD Biotechnology Company Information

6.4.2 Shenzhen BIOCBD Biotechnology Description and Business Overview

6.4.3 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio

6.4.5 Shenzhen BIOCBD Biotechnology Recent Developments/Updates

6.5 Jinyu Biotechnology

6.5.1 Jinyu Biotechnology Company Information

6.5.2 Jinyu Biotechnology Description and Business Overview

6.5.3 Jinyu Biotechnology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio

6.5.5 Jinyu Biotechnology Recent Developments/Updates

6.6 Zhongmu Industry

6.6.1 Zhongmu Industry Company Information

6.6.2 Zhongmu Industry Description and Business Overview

6.6.3 Zhongmu Industry Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zhongmu Industry Swine Inactive Vaccine Product Portfolio

6.6.5 Zhongmu Industry Recent Developments/Updates

6.7 Qindao Lijian Bio-Tech

6.7.1 Qindao Lijian Bio-Tech Company Information

6.7.2 Qindao Lijian Bio-Tech Description and Business Overview

6.7.3 Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio

6.7.5 Qindao Lijian Bio-Tech Recent Developments/Updates

6.8 Wuhan Keqian Biology

6.8.1 Wuhan Keqian Biology Company Information

6.8.2 Wuhan Keqian Biology Description and Business Overview

6.8.3 Wuhan Keqian Biology Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio

6.8.5 Wuhan Keqian Biology Recent Developments/Updates

6.9 Shenlian Biomedical

6.9.1 Shenlian Biomedical Company Information

6.9.2 Shenlian Biomedical Description and Business Overview

6.9.3 Shenlian Biomedical Swine Inactive Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shenlian Biomedical Swine Inactive Vaccine Product Portfolio

6.9.5 Shenlian Biomedical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Swine Inactive Vaccine Industry Chain Analysis

7.2 Swine Inactive Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Swine Inactive Vaccine Production Mode & Process Analysis

7.4 Swine Inactive Vaccine Sales and Marketing

7.4.1 Swine Inactive Vaccine Sales Channels

7.4.2 Swine Inactive Vaccine Distributors

7.5 Swine Inactive Vaccine Customer Analysis

8 Swine Inactive Vaccine Market Dynamics

8.1 Swine Inactive Vaccine Industry Trends

8.2 Swine Inactive Vaccine Market Drivers

8.3 Swine Inactive Vaccine Market Challenges

8.4 Swine Inactive Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim

Harbin Pharmaceutical Group Bio-vaccine

DHN

Shenzhen BIOCBD Biotechnology

Jinyu Biotechnology

Zhongmu Industry

Qindao Lijian Bio-Tech

Wuhan Keqian Biology

Shenlian Biomedical

List of Tables

Table 1. Global Swine Inactive Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Swine Inactive Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Swine Inactive Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Swine Inactive Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Swine Inactive Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Swine Inactive Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Swine Inactive Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Swine Inactive Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Swine Inactive Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Swine Inactive Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Swine Inactive Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Swine Inactive Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Swine Inactive Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Inactive Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Swine Inactive Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Swine Inactive Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Swine Inactive Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Swine Inactive Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Swine Inactive Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Swine Inactive Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Swine Inactive Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Swine Inactive Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Swine Inactive Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Swine Inactive Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Swine Inactive Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Swine Inactive Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Swine Inactive Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Swine Inactive Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Swine Inactive Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Swine Inactive Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Swine Inactive Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Swine Inactive Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Swine Inactive Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Swine Inactive Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Swine Inactive Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Swine Inactive Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Swine Inactive Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Swine Inactive Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Swine Inactive Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Swine Inactive Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Swine Inactive Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Swine Inactive Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Swine Inactive Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Swine Inactive Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Swine Inactive Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Swine Inactive Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Swine Inactive Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Swine Inactive Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Swine Inactive Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Swine Inactive Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Swine Inactive Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Swine Inactive Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Swine Inactive Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Swine Inactive Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Swine Inactive Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Swine Inactive Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Swine Inactive Vaccine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Swine Inactive Vaccine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Swine Inactive Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Swine Inactive Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Swine Inactive Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Swine Inactive Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Swine Inactive Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Swine Inactive Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Swine Inactive Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Swine Inactive Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Swine Inactive Vaccine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Swine Inactive Vaccine Price (USD/Unit) by Application (2026-2031)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Swine Inactive Vaccine Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Harbin Pharmaceutical Group Bio-vaccine Company Information

Table 76. Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview

Table 77. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product

Table 79. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates

Table 80. DHN Company Information

Table 81. DHN Description and Business Overview

Table 82. DHN Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. DHN Swine Inactive Vaccine Product

Table 84. DHN Recent Developments/Updates

Table 85. Shenzhen BIOCBD Biotechnology Company Information

Table 86. Shenzhen BIOCBD Biotechnology Description and Business Overview

Table 87. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product

Table 89. Shenzhen BIOCBD Biotechnology Recent Developments/Updates

Table 90. Jinyu Biotechnology Company Information

Table 91. Jinyu Biotechnology Description and Business Overview

Table 92. Jinyu Biotechnology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Jinyu Biotechnology Swine Inactive Vaccine Product

Table 94. Jinyu Biotechnology Recent Developments/Updates

Table 95. Zhongmu Industry Company Information

Table 96. Zhongmu Industry Description and Business Overview

Table 97. Zhongmu Industry Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Zhongmu Industry Swine Inactive Vaccine Product

Table 99. Zhongmu Industry Recent Developments/Updates

Table 100. Qindao Lijian Bio-Tech Company Information

Table 101. Qindao Lijian Bio-Tech Description and Business Overview

Table 102. Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Qindao Lijian Bio-Tech Swine Inactive Vaccine Product

Table 104. Qindao Lijian Bio-Tech Recent Developments/Updates

Table 105. Wuhan Keqian Biology Company Information

Table 106. Wuhan Keqian Biology Description and Business Overview

Table 107. Wuhan Keqian Biology Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Wuhan Keqian Biology Swine Inactive Vaccine Product

Table 109. Wuhan Keqian Biology Recent Developments/Updates

Table 110. Shenlian Biomedical Company Information

Table 111. Shenlian Biomedical Description and Business Overview

Table 112. Shenlian Biomedical Swine Inactive Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Shenlian Biomedical Swine Inactive Vaccine Product

Table 114. Shenlian Biomedical Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Swine Inactive Vaccine Distributors List

Table 118. Swine Inactive Vaccine Customers List

Table 119. Swine Inactive Vaccine Market Trends

Table 120. Swine Inactive Vaccine Market Drivers

Table 121. Swine Inactive Vaccine Market Challenges

Table 122. Swine Inactive Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Swine Inactive Vaccine

Figure 2. Global Swine Inactive Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Swine Inactive Vaccine Market Share by Type: 2024 & 2031

Figure 4. Mycoplasma Hyopneumoniae Bacterin Vaccine Product Picture

Figure 5. Haemophilus Parasuis Vaccine Product Picture

Figure 6. Porcine Circovirus Type 2 Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Swine Inactive Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Swine Inactive Vaccine Market Share by Application: 2024 & 2031

Figure 10. Breeding Farm

Figure 11. Veterinary Clinic

Figure 12. Global Swine Inactive Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Swine Inactive Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Swine Inactive Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global Swine Inactive Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 16. Swine Inactive Vaccine Report Years Considered

Figure 17. Swine Inactive Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Swine Inactive Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Swine Inactive Vaccine Players: Market Share by Revenue in Swine Inactive Vaccine in 2024

Figure 20. Swine Inactive Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Swine Inactive Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Swine Inactive Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Swine Inactive Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. United States Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Swine Inactive Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Swine Inactive Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Swine Inactive Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Swine Inactive Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Swine Inactive Vaccine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Swine Inactive Vaccine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Swine Inactive Vaccine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Swine Inactive Vaccine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Swine Inactive Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Swine Inactive Vaccine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Swine Inactive Vaccine by Type (2020-2031)

Figure 56. Global Swine Inactive Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Swine Inactive Vaccine by Application (2020-2031)

Figure 58. Global Revenue Market Share of Swine Inactive Vaccine by Application (2020-2031)

Figure 59. Global Swine Inactive Vaccine Price (USD/Unit) by Application (2020-2031)

Figure 60. Swine Inactive Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions